Literature DB >> 32535679

Clinical and pathological features in adult-onset NIID patients with cortical enhancement.

Huiting Liang1, Bo Wang1, Qing Li1, Jianwen Deng2, Lulu Wang1, Huan Wang1, Xiaobin Li1, Min Zhu1, Yu Cai3, Zhaoxia Wang2, Yun Yuan2, Pu Fang4, Daojun Hong5.   

Abstract

BACKGROUND: Neuronal intranuclear inclusion disease (NIID) is a neurodegenerative disease characterized by eosinophilic hyaline intranuclear inclusions in multiple organs. On conventional MRI, high signals on diffused weight image (DWI) along the corticomedullary junction have demonstrated great diagnostic values for adult-onset NIID. However, changes of contrast MRI in the acute period of the encephalopathy-like episode have rarely been investigated.
METHODS: Patients with enhanced lesions were retrieved in our database including 35 patients with adult-onset NIID between October 2017 and December 2019. Conventional and contrast MRI were conducted in all patients. Standard procedures of skin biopsy were performed in all patients. Repeat-primed PCR and amplicon length PCR were used to screen the GGC expansion in the 5'UTR of the NOTCH2NLC gene.
RESULTS: Four of 35 patients (11.4%) were identified to have a cortical enhancement in this study. The enhanced lesions were selectively spread along the surface of posterior cortex and were clinically associated with encephalopathy-like episodes. These patients had a younger age of onset, shorter duration of disease, and a higher incidence of a headache than those without enhancement. Typical p62-postive intranuclear inclusions were observed in all patients, while patient 1 simultaneously had many nuclei full of abnormal substance immunopositive to p62, as well as short-curly filament materials on electron microscopy. All patients were identified to have GGC repeat expansion in the NOTCH2NLC gene.
CONCLUSION: Post-contrast MRI should be routinely performed in the adult-onset NIID patients. Some patients with adult-onset NIID showed cortical enhancement and edema along the surface of posterior cortex, indicating that dehydrate and anti-inflammatory drugs might be potential therapies for these patients.

Entities:  

Keywords:  Cortical edema; Encephalopathic episode; MRI enhancement; NOTCH2NLC; Neuronal intranuclear inclusion disease

Mesh:

Year:  2020        PMID: 32535679     DOI: 10.1007/s00415-020-09945-7

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  15 in total

Review 1.  Neuronal intranuclear inclusion disease: recognition and update.

Authors:  Xi Lu; Daojun Hong
Journal:  J Neural Transm (Vienna)       Date:  2021-02-18       Impact factor: 3.575

Review 2.  The Phenotypes and Mechanisms of NOTCH2NLC-Related GGC Repeat Expansion Disorders: a Comprehensive Review.

Authors:  Xiu-Rong Huang; Bei-Sha Tang; Peng Jin; Ji-Feng Guo
Journal:  Mol Neurobiol       Date:  2021-10-31       Impact factor: 5.590

3.  Absence of diffusion-weighted imaging abnormalities in a patient with neuronal intranuclear inclusion disease.

Authors:  Keisuke Mizutani; Keita Sakurai; Yuto Uchida; Takuya Oguri; Hideki Kato; Mari Yoshida; Jun Sone; Hiroyuki Yuasa; Noriyuki Matsukawa
Journal:  Neurol Sci       Date:  2022-07-15       Impact factor: 3.830

4.  CGG repeat expansion in NOTCH2NLC causes mitochondrial dysfunction and progressive neurodegeneration in Drosophila model.

Authors:  Jiaxi Yu; Tongling Liufu; Yilei Zheng; Jin Xu; Lingchao Meng; Wei Zhang; Yun Yuan; Daojun Hong; Nicolas Charlet-Berguerand; Zhaoxia Wang; Jianwen Deng
Journal:  Proc Natl Acad Sci U S A       Date:  2022-10-03       Impact factor: 12.779

Review 5.  Neurodegenerative diseases associated with non-coding CGG tandem repeat expansions.

Authors:  Zhi-Dong Zhou; Joseph Jankovic; Tetsuo Ashizawa; Eng-King Tan
Journal:  Nat Rev Neurol       Date:  2022-01-12       Impact factor: 44.711

6.  Characteristics of ocular findings of patients with neuronal intranuclear inclusion disease.

Authors:  Chang Liu; Xinghua Luan; Xiaohong Liu; Xiangning Wang; Xuan Cai; Tingting Li; Li Cao; Da Long
Journal:  Neurol Sci       Date:  2021-11-19       Impact factor: 3.830

Review 7.  NOTCH2NLC-related repeat expansion disorders: an expanding group of neurodegenerative disorders.

Authors:  Lanxiao Cao; Yaping Yan; Guohua Zhao
Journal:  Neurol Sci       Date:  2021-08-01       Impact factor: 3.307

8.  GGC repeat expansions in NOTCH2NLC causing a phenotype of distal motor neuropathy and myopathy.

Authors:  Jiaxi Yu; Xing-Hua Luan; Meng Yu; Wei Zhang; He Lv; Li Cao; Lingchao Meng; Min Zhu; Binbin Zhou; Xiao-Rong Wu; Pidong Li; Qiang Gang; Jing Liu; Xin Shi; Wei Liang; Zhirong Jia; Sheng Yao; Yun Yuan; Jianwen Deng; Daojun Hong; Zhaoxia Wang
Journal:  Ann Clin Transl Neurol       Date:  2021-05-04       Impact factor: 4.511

9.  Case of Neuronal Intranuclear Inclusion Disease With Dynamic Perfusion Changes Lacking Typical Signs on Diffusion-Weighted Imaging.

Authors:  Mai Kikumoto; Tomohisa Nezu; Yuji Shiga; Atsuko Motoda; Megumi Toko; Takashi Kurashige; Hiroki Ueno; Tetsuya Takahashi; Hiroyuki Morino; Jun Sone; Yasushi Iwasaki; Gen Sobue; Hirofumi Maruyama
Journal:  Neurol Genet       Date:  2021-06-09

10.  The GGC repeat expansion in NOTCH2NLC is associated with oculopharyngodistal myopathy type 3.

Authors:  Jiaxi Yu; Jianwen Deng; Xueyu Guo; Jingli Shan; Xinghua Luan; Li Cao; Juan Zhao; Meng Yu; Wei Zhang; He Lv; Zhiying Xie; LingChao Meng; Yiming Zheng; Yawen Zhao; Qiang Gang; Qingqing Wang; Jing Liu; Min Zhu; Binbin Zhou; Pidong Li; Yinzhe Liu; Yang Wang; Chuanzhu Yan; Daojun Hong; Yun Yuan; Zhaoxia Wang
Journal:  Brain       Date:  2021-07-28       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.